PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1993 November; 86(11): 634–636.
PMCID: PMC1294219

Temporary prostatic stenting and androgen suppression: a new minimally invasive approach to malignant prostatic retention.

Abstract

Urinary retention secondary to carcinoma of the prostate is usually treated by 'channel' transurethral resection of the prostate either performed alone or in combination with hormone manipulation. The combination of temporary prostatic stenting and androgen suppression may reduce the morbidity and mortality associated with this treatment. We report on our initial experience using the combination of a temporary prostatic stent with the oral anti-androgen Flutamide in 10 patients with urinary retention or severe bladder outflow obstruction secondary to prostatic carcinoma. Eight of the ten patients successfully voided and maintained normal voiding after stent removal. There were two treatment failures requiring prostatic resection. We believe the cost of stenting and medication is entirely justified by patient preference and clearance of hospital beds.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (633K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Thomas DJ, Balaji VJ, Coptcoat MJ, Abercrombie GF. Acute urinary retention secondary to carcinoma of the prostate. Is initial channel TURP beneficial? J R Soc Med. 1992 Jun;85(6):318–319. [PMC free article] [PubMed]
  • Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989 Feb;141(2):243–247. [PubMed]
  • Birch BR, Anson KM, Miller RA. Sedoanalgesia in urology: a safe, cost-effective alternative to general anaesthesia. A review of 1020 cases. Br J Urol. 1990 Oct;66(4):342–350. [PubMed]
  • Hwang TI, Yang CR, Wang SJ, Chang CL, Tzai TS, Chang CH, Wu HC. Impotence evaluated by the use of prostaglandin E1. J Urol. 1989 Jun;141(6):1357–1359. [PubMed]
  • Mazur AW, Thompson IM. Efficacy and morbidity of "channel" TURP. Urology. 1991 Dec;38(6):526–528. [PubMed]
  • Harrison NW, De Souza JV. Prostatic stenting for outflow obstruction. Br J Urol. 1990 Feb;65(2):192–196. [PubMed]
  • Nielsen KK, Klarskov P, Nordling J, Andersen JT, Holm HH. The intraprostatic spiral. New treatment for urinary retention. Br J Urol. 1990 May;65(5):500–503. [PubMed]
  • Nordling J, Holm HH, Klarskov P, Nielsen KK, Andersen JT. The intraprostatic spiral: a new device for insertion with the patient under local anesthesia and with ultrasonic guidance with 3 months of followup. J Urol. 1989 Sep;142(3):756–758. [PubMed]
  • Nordling J, Ovesen H, Poulsen AL. The intraprostatic spiral: clinical results in 150 consecutive patients. J Urol. 1992 Mar;147(3):645–647. [PubMed]
  • Van Poppel H, Baert L, Aswarie H, Oyen R. Experience with the intraprostatic spiral. Br J Urol. 1991 Dec;68(6):604–607. [PubMed]
  • Nissenkorn I. Experience with a new self-retaining intraurethral catheter in patients with urinary retention: a preliminary report. J Urol. 1989 Jul;142(1):92–94. [PubMed]
  • Poulsen AL, Ovesen H, Nielsen KK, Kromann-Andersen B, Nordling J. Intraprostatic spiral during waiting time for transurethral prostatectomy. Urol Int. 1991;46(2):172–175. [PubMed]
  • Fleischmann JD, Catalona WJ. Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol. 1985 Sep;134(3):498–500. [PubMed]
  • Sogani PC, Whitmore WF., Jr Experience with flutamide in previously untreated patients with advanced prostatic cancer. J Urol. 1979 Nov;122(5):640–643. [PubMed]
  • Sogani PC, Vagaiwala MR, Whitmore WF., Jr Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy. Cancer. 1984 Aug 15;54(4):744–750. [PubMed]
  • Lund F, Rasmussen F. Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study. Br J Urol. 1988 Feb;61(2):140–142. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press